In Brief: Comparing the antidepressants

In Brief

Comparing the antidepressants

A review suggests that the many antidepressant drugs introduced since the mid-1980s are all about equally effective.

The survey covers 46 head-to-head comparisons between antidepressants. Most of the drugs included are selective serotonin reuptake inhibitors (SSRIs): citalopram (Celexa), escitalopram (Lexapro), fluoxetine (Prozac), fluvoxamine (Luvox), paroxetine (Paxil), and sertraline (Zoloft). Also tested were several drugs that have a different mechanism of action, inhibiting the reuptake of norepinephrine alone or various combinations of neurotransmitters: bupropion (Wellbutrin), venlafaxine (Effexor), duloxetine (Cymbalta), and mirtazapine (Remeron). About half of the trials compared two SSRIs, and the rest compared an SSRI with one of the newer drugs. More than 90% of the trials showed no more than a chance difference in effectiveness between the two drugs. When several studies directly compared two drugs, the investigators combined the results for a meta-analysis. In these calculations, sertraline and venlafaxine proved to be slightly more effective than fluoxetine. Mirtazapine consistently, and venlafaxine in a few studies, produced a slightly faster response than SSRIs.

To continue reading this article, you must login.
  • Research health conditions
  • Check your symptoms
  • Prepare for a doctor's visit or test
  • Find the best treatments and procedures for you
  • Explore options for better nutrition and exercise
Learn more about the many benefits and features of joining Harvard Health Online »